Use of liposome‐associated bupivacaine in a cancer pain syndrome
- 1 June 1996
- journal article
- case report
- Published by Wiley in Anaesthesia
- Vol. 51 (6) , 578-579
- https://doi.org/10.1111/j.1365-2044.1996.tb12569.x
Abstract
Bupivacaine 0.25% encapsulated by multilamellar liposomes was administered epidurally to a patient suffering pain associated with lung cancer and the effect compared with a plain bupivacaine solution of the same concentration. Complete analgesia was produced for 4 h with the plain solution and 11 h with the liposomal formulation. No motor blockade or haemodynamic instability was observed with the liposome-associated bupivacaine.Keywords
This publication has 14 references indexed in Scilit:
- Biodistribution of liposome-associated bupivacaine after extradural administration to rabbitsBritish Journal of Anaesthesia, 1995
- Use of Liposome-Associated Bupivacaine for the Management of a Chronic Pain SyndromeAnesthesia & Analgesia, 1994
- Epidural administration of liposome associated bupivacaine for the management of postsurgical pain: A first studyJournal of Clinical Anesthesia, 1994
- Toxicity of Bupivacaine Encapsulated into Liposomes and Injected IntravenouslyAnesthesia & Analgesia, 1993
- Bupivacaine-Induced Cardiac ArrestAnesthesia & Analgesia, 1990
- Long-acting Local Anesthetic Drugs and Convulsions with Hypoxia and AcidosisAnesthesiology, 1982
- CEREBRAL AND CIRCULATORY EFFECTS OF HIGH-DOSE BUPIVACAINE AND ETIDOCAINEAnesthesiology, 1980
- Cardiac Arrest Following Regional Anesthesia with Etidocaine or BupivacaineAnesthesiology, 1979
- Local Anaesthetics and their Current Clinical UseDrugs, 1979
- Convulsive Arterial Plasma Levels of Bupivacaine and the Response to Diazepam TherapyAnesthesiology, 1979